Literature DB >> 12955365

Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells.

Nobuyuki Hinata1, Toshiro Shirakawa, Zhujun Zhang, Akira Matsumoto, Masato Fujisawa, Hiroshi Okada, Sadao Kamidono, Akinobu Gotoh.   

Abstract

UNLABELLED: Purpose. It has been reported in several studies that the absence in cancer cells of the p53 tumor suppressor gene, mutations of which are frequently found in bladder cancer, increases their resistance to ionizing radiation. Other studies, however, suggest that mutations of the p53 gene could increase the radiosensitivity of cancer cells, although the evidence is still inconclusive. In the present study, we investigated the relationship between p53 status and radiation response in five different bladder cancer cell lines. Materials and Methods. Five different human bladder cancer cell lines (KK47: with wt- p53, RT4: with wt- p53, T24: with mutated p53, 5637: with mutated p53, UM-UC-3: with mutated p53) were used in the study. Cells were irradiated with 0, 2, 4, 6 or 8 Gy, then trypsinized and re-plated for clonogenic survival assay, quantitative RT-PCR assay, flow-cytometry analysis and TUNEL assay. Results. The clonogenic assay demonstrated that KK47 and RT4 had significantly higher radiosensitivity than other cell lines. Quantitative RT-PCR analysis showed that radiation induced increased expression of p53, Bax, and p21 mRNA in KK47 and RT4. After irradiation, G1 cell-cycle arrest was observed in KK47 and RT4 under flow cytometry analysis, while T24, 5637, and UM-UC-3 showed an increase in the proportion of G2 cells. Increased cell apoptosis was also observed under TUNEL assay in KK47 and RT4, but not in other cell lines.
CONCLUSIONS: It was demonstrated that ionizing radiation induces p53-dependent cell apoptosis in bladder cancer cells with wt- p53 but not in those with mutated p53.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955365     DOI: 10.1007/s00240-003-0355-9

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  37 in total

1.  Real-time quantitative polymerase chain reaction to assess gene transfer.

Authors:  K Becker; D Pan; C B Whitley
Journal:  Hum Gene Ther       Date:  1999-10-10       Impact factor: 5.695

2.  Acetylcholine receptor assembly: subunit folding and oligomerization occur sequentially.

Authors:  W N Green; T Claudio
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

3.  Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development.

Authors:  D S Biard; M Martin; Y L Rhun; A Duthu; J L Lefaix; E May; P May
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

4.  p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancer.

Authors:  R Shipman; P Schraml; H Moch; M Colombi; G Sauter; M Mihatsch; C Ludwig
Journal:  Int J Oncol       Date:  1997-04       Impact factor: 5.650

5.  Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.

Authors:  M H Hussain; T R Glass; J Forman; W Sakr; D C Smith; M Al-Sarraf; J Jones; S P Balcerzak; E D Crawford; H B Grossman
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

6.  p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.

Authors:  D G Brachman; M Beckett; D Graves; D Haraf; E Vokes; R R Weichselbaum
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

7.  Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.

Authors:  K J Russell; L W Wiens; G W Demers; D A Galloway; S E Plon; M Groudine
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

Review 8.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

9.  p53 mutations increase resistance to ionizing radiation.

Authors:  J M Lee; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: an immunohistochemical study.

Authors:  I Osen; S D Fosså; B Majak; R Røtterud; A Berner
Journal:  Br J Urol       Date:  1998-06
View more
  13 in total

1.  mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status.

Authors:  Charles B Simone; Molykutty John-Aryankalayil; Sanjeewani T Palayoor; Adeola Y Makinde; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  Transl Oncol       Date:  2013-10-01       Impact factor: 4.243

2.  Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28.

Authors:  Ines Müller; Elwira Strozyk; Sebastian Schindler; Stefan Beissert; Htoo Zarni Oo; Thomas Sauter; Philippe Lucarelli; Sebastian Raeth; Angelika Hausser; Nader Al Nakouzi; Ladan Fazli; Martin E Gleave; He Liu; Hans-Uwe Simon; Henning Walczak; Douglas R Green; Jiri Bartek; Mads Daugaard; Dagmar Kulms
Journal:  Mol Cell       Date:  2020-01-22       Impact factor: 17.970

3.  Heme oxygenase-1 accelerates protumoral effects of nitric oxide in cancer cells.

Authors:  Takamitsu Sasaki; Kazuhiro Yoshida; Hideaki Kondo; Hitoshi Ohmori; Hiroki Kuniyasu
Journal:  Virchows Arch       Date:  2005-04-15       Impact factor: 4.064

4.  Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells.

Authors:  Glenda N da Silva; Adriane F Evangelista; Danielle A Magalhães; Cláudia Macedo; Michelle C Búfalo; Elza T Sakamoto-Hojo; Geraldo A S Passos; Daisy M F Salvadori
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

5.  MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.

Authors:  Ananya Choudhury; Louisa D Nelson; Mark T W Teo; Sameer Chilka; Selina Bhattarai; Colin F Johnston; Faye Elliott; Johanna Lowery; Claire F Taylor; Michael Churchman; Johanne Bentley; Margaret A Knowles; Patricia Harnden; Robert G Bristow; D Timothy Bishop; Anne E Kiltie
Journal:  Cancer Res       Date:  2010-09-15       Impact factor: 12.701

6.  RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP2.

Authors:  Yaqi Chen; Sha Zhou; Kairui Wan; Long Yu; Chongchong Zhao; Haiteng Deng; Qingjian Ou; Jiayi Qin; Junbo Hu; Zhenlin Hou
Journal:  Oncogene       Date:  2022-05-19       Impact factor: 8.756

7.  NF-κB1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1.

Authors:  Y Yu; D Zhang; H Huang; J Li; M Zhang; Y Wan; J Gao; C Huang
Journal:  Oncogene       Date:  2013-02-11       Impact factor: 9.867

8.  Use of the comet-FISH assay to compare DNA damage and repair in p53 and hTERT genes following ionizing radiation.

Authors:  Declan J McKenna; Bernadette A Doherty; C Stephen Downes; Stephanie R McKeown; Valerie J McKelvey-Martin
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 9.  Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer.

Authors:  Dmitriy Smolensky; Kusum Rathore; Maria Cekanova
Journal:  Drug Des Devel Ther       Date:  2016-10-05       Impact factor: 4.162

10.  Methotrexate-coupled nanoparticles and magnetic nanochemothermia for the relapse-free treatment of T24 bladder tumors.

Authors:  Marcus Stapf; Ulf Teichgräber; Ingrid Hilger
Journal:  Int J Nanomedicine       Date:  2017-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.